Hereditary inclusion-body myopathies

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1852, Issue 4, 2015, Pages 644-650

  Broccolini, Aldobrando ^a   Mirabella, Massimiliano ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

GNE myopathy; HIBM; IBMPFD; Myosin Heavy Chain; VCP

Indexed keywords

URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE 2 EPIMERASE; MYOSIN HEAVY CHAIN; N ACETYLNEURAMINIC ACID;

CLINICAL FEATURE; EXTERNAL OPHTHALMOPLEGIA; FRONTOTEMPORAL DEMENTIA; GENETIC VARIABILITY; HEREDITARY INCLUSION BODY MYOPATHY; HUMAN; JOINT CONTRACTURE; MOLECULAR PATHOLOGY; MUSCLE DISEASE; MYOPATHY; NONHUMAN; PAGET BONE DISEASE; PRIORITY JOURNAL; REVIEW; ANIMAL; CONTRACTURE; ENZYMOLOGY; GENETICS; LIMB GIRDLE MUSCULAR DYSTROPHY; METABOLISM; MUTATION; MYOSITIS, INCLUSION BODY; OPHTHALMOPLEGIA; PATHOLOGY; PROTEIN PROCESSING; SKELETAL MUSCLE;

ANIMALS; CONTRACTURE; FRONTOTEMPORAL DEMENTIA; HUMANS; MUSCLE FIBERS, SKELETAL; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; MUTATION; MYOSIN HEAVY CHAINS; MYOSITIS, INCLUSION BODY; N-ACETYLNEURAMINIC ACID; OPHTHALMOPLEGIA; OSTEITIS DEFORMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84922284091     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.08.007     Document Type: Review

References (55)

1. Askanas V., Engel W.K. New advances in inclusion-body myositis. Curr Opin Rheumatol 1993, 5:732-741.
2. Askanas V., Engel W.K. Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: current concepts of diagnosis and pathogenesis. Curr Opin Rheumatol 1998, 10:530-542.
3. Argov Z., Yarom R. "Rimmed vacuole myopathy" sparing the quadriceps. A unique disorder in Iranian Jews, J Neurol Sci 1984, 64:33-43.
4. Eisenberg I., Avidan N., Potikha T., Hochner H., Chen M., Olender T., Barash M., Shemesh M., Sadeh M., Grabov-Nardini G., Shmilevich I., Friedmann A., Karpati G., Bradley W.G., Baumbach L., Lancet D., Asher E.B., Beckmann J.S., Argov Z., Mitrani-Rosenbaum S. The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nat Genet 2001, 29:83-87.
5. Hinderlich S., Stasche R., Zeitler R., Reutter W. A bifunctional enzyme catalyzes the first two steps in N-acetylneuraminic acid biosynthesis of rat liver. Purification and characterization of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase. J Biol Chem 1997, 272:24313-24318.
6. Argov Z., Eisenberg I., Grabov-Nardini G., Sadeh M., Wirguin I., Soffer D., Mitrani-Rosenbaum S. Hereditary inclusion body myopathy: the Middle Eastern genetic cluster. Neurology 2003, 60:1519-1523.
7. Eisenberg I., Grabov-Nardini G., Hochner H., Korner M., Sadeh M., Bertorini T., Bushby K., Castellan C., Felice K., Mendell J., Merlini L., Shilling C., Wirguin I., Argov Z., Mitrani-Rosenbaum S. Mutations spectrum of GNE in hereditary inclusion body myopathy sparing the quadriceps. Hum Mutat 2003, 21:99.
8. Kayashima T., Matsuo H., Satoh A., Ohta T., Yoshiura K., Matsumoto N., Nakane Y., Niikawa N., Kishino T. Nonaka myopathy is caused by mutations in the UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase gene (GNE). J Hum Genet 2002, 47:77-79.
9. Nishino I., Noguchi S., Murayama K., Driss A., Sugie K., Oya Y., Nagata T., Chida K., Takahashi T., Takusa Y., Ohi T., Nishimiya J., Sunohara N., Ciafaloni E., Kawai M., Aoki M., Nonaka I. Distal myopathy with rimmed vacuoles is allelic to hereditary inclusion body myopathy. Neurology 2002, 59:1689-1693.
10. Broccolini A., Ricci E., Cassandrini D., Gliubizzi C., Bruno C., Tonoli E., Silvestri G., Pescatori M., Rodolico C., Sinicropi S., Servidei S., Zara F., Minetti C., Tonali P.A., Mirabella M. Novel GNE mutations in Italian families with autosomal recessive hereditary inclusion-body myopathy. Hum Mutat 2004, 23:632.
11. Broccolini A., Gidaro T., Tasca G., Morosetti R., Rodolico C., Ricci E., Mirabella M. Analysis of NCAM helps identify unusual phenotypes of hereditary inclusion-body myopathy. Neurology 2010, 75:265-272.
12. Ricci E., Broccolini A., Gidaro T., Morosetti R., Gliubizzi C., Frusciante R., Di Lella G.M., Tonali P.A., Mirabella M. NCAM is hyposialylated in hereditary inclusion body myopathy due to GNE mutations. Neurology 2006, 66:755-758.
13. Tasca G., Ricci E., Monforte M., Laschena F., Ottaviani P., Rodolico C., Barca E., Silvestri G., Iannaccone E., Mirabella M., Broccolini A. Muscle imaging findings in GNE myopathy. J Neurol 2012, 259:1358-1365.
14. Cho A., Hayashi Y.K., Monma K., Oya Y., Noguchi S., Nonaka I., Nishino I. Mutation profile of the GNE gene in Japanese patients with distal myopathy with rimmed vacuoles (GNE myopathy). J Neurol Neurosurg Psychiatry 2014, 85:914-917.
15. Malicdan M.C., Noguchi S., Nonaka I., Hayashi Y.K., Nishino I. A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy. Hum Mol Genet 2007, 16:2669-2682.
16. A. Broccolini, C. Gliubizzi, E. Pavoni, T. Gidaro, R. Morosetti, F. Sciandra, B. Giardina, P. Tonali, E. Ricci, A. Brancaccio, M. Mirabella, alpha-Dystroglycan does not play a major pathogenic role in autosomal recessive hereditary inclusion-body myopathy, Neuromuscul Disord, 15 (2005) 177-184.
17. Valles-Ayoub Y., Esfandiarifard S., Sinai P., Carbajo R., Khokher Z., No D., Pietruszka M., Darvish B., Kakkis E., Darvish D. Serum neural cell adhesion molecule is hyposialylated in hereditary inclusion body myopathy. Genet Test Mol Biomarkers 2012, 16:313-317.
18. Grover S., Arya R. Role of UDP-N-acetylglucosamine2-epimerase/N-acetylmannosamine kinase (GNE) in beta1-integrin-mediated cell adhesion. Molecular Neurobiology 2014, 10.1007/s12035-013-8604-6.
19. Askanas V., Engel W.K., Alvarez R.B. Light and electron microscopic localization of beta-amyloid protein in muscle biopsies of patients with inclusion-body myositis. Am J Pathol 1992, 141:31-36.
20. Broccolini A., Gidaro T., De Cristofaro R., Morosetti R., Gliubizzi C., Ricci E., Tonali P.A., Mirabella M. Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion-body myopathy muscle. J Neurochem 2008, 105:971-981.
21. Malicdan M.C., Noguchi S., Tokutomi T., Goto Y., Nonaka I., Hayashi Y.K., Nishino I. Peracetylated N-acetylmannosamine, a synthetic sugar molecule, efficiently rescues muscle phenotype and biochemical defects in mouse model of sialic acid-deficient myopathy. J Biol Chem 2012, 287:2689-2705.
22. Ni M., Lee A.S. ER chaperones in mammalian development and human diseases. FEBS Lett 2007, 581:3641-3651.
23. Li H., Chen Q., Liu F., Zhang X., Li W., Liu S., Zhao Y., Gong Y., Yan C. Unfolded protein response and activated degradative pathways regulation in GNE myopathy. PLoS One 2013, 8:e58116.
24. Sparks S., Rakocevic G., Joe G., Manoli I., Shrader J., Harris-Love M., Sonies B., Ciccone C., Dorward H., Krasnewich D., Huizing M., Dalakas M.C., Gahl W.A. Intravenous immune globulin in hereditary inclusion body myopathy: a pilot study. BMC Neurol 2007, 7:3.
25. Hinderlich S., Berger M., Keppler O.T., Pawlita M., Reutter W. Biosynthesis of N-acetylneuraminic acid in cells lacking UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase. Biol Chem 2001, 382:291-297.
26. Malicdan M.C., Noguchi S., Hayashi Y.K., Nonaka I., Nishino I. Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model. Nat Med 2009, 15:690-695.
27. Watts G.D., Wymer J., Kovach M.J., Mehta S.G., Mumm S., Darvish D., Pestronk A., Whyte M.P., Kimonis V.E. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 2004, 36:377-381.
28. Weihl C.C. Valosin containing protein associated fronto-temporal lobar degeneration: clinical presentation, pathologic features and pathogenesis. Curr Alzheimer Res 2011, 8:252-260.
29. Watts G.D., Thomasova D., Ramdeen S.K., Fulchiero E.C., Mehta S.G., Drachman D.A., Weihl C.C., Jamrozik Z., Kwiecinski H., Kaminska A., Kimonis V.E. Novel VCP mutations in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia. Clin Genet 2007, 72:420-426.
30. Hubbers C.U., Clemen C.S., Kesper K., Boddrich A., Hofmann A., Kamarainen O., Tolksdorf K., Stumpf M., Reichelt J., Roth U., Krause S., Watts G., Kimonis V., Wattjes M.P., Reimann J., Thal D.R., Biermann K., Evert B.O., Lochmuller H., Wanker E.E., Schoser B.G., Noegel A.A., Schroder R. Pathological consequences of VCP mutations on human striated muscle. Brain 2007, 130:381-393.
31. Zatloukal K., Stumptner C., Fuchsbichler A., Heid H., Schnoelzer M., Kenner L., Kleinert R., Prinz M., Aguzzi A., Denk H. p62 is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol 2002, 160:255-263.
32. Mirabella M., Alvarez R.B., Bilak M., Engel W.K., Askanas V. Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies. J Neuropathol Exp Neurol 1996, 55:774-786.
33. Greenberg S.A., Watts G.D., Kimonis V.E., Amato A.A., Pinkus J.L. Nuclear localization of valosin-containing protein in normal muscle and muscle affected by inclusion-body myositis. Muscle Nerve 2007, 36:447-454.
34. Schroder R., Watts G.D., Mehta S.G., Evert B.O., Broich P., Fliessbach K., Pauls K., Hans V.H., Kimonis V., Thal D.R. Mutant valosin-containing protein causes a novel type of frontotemporal dementia. Ann Neurol 2005, 57:457-461.
35. Cairns N.J., Bigio E.H., Mackenzie I.R., Neumann M., Lee V.M., Hatanpaa K.J., White C.L., Schneider J.A., Grinberg L.T., Halliday G., Duyckaerts C., Lowe J.S., Holm I.E., Tolnay M., Okamoto K., Yokoo H., Murayama S., Woulfe J., Munoz D.G., Dickson D.W., Ince P.G., Trojanowski J.Q., Mann D.M. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 2007, 114:5-22.
36. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., Lee V.M. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133.
37. Weihl C.C., Temiz P., Miller S.E., Watts G., Smith C., Forman M., Hanson P.I., Kimonis V., Pestronk A. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry 2008, 79:1186-1189.
38. Salajegheh M., Pinkus J.L., Taylor J.P., Amato A.A., Nazareno R., Baloh R.H., Greenberg S.A. Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis. Muscle Nerve 2009, 40:19-31.
39. Dai R.M., Li C.C. Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation. Nat Cell Biol 2001, 3:740-744.
40. Jarosch E., Geiss-Friedlander R., Meusser B., Walter J., Sommer T. Protein dislocation from the endoplasmic reticulum-pulling out the suspect. Traffic 2002, 3:530-536.
41. Rabouille C., Kondo H., Newman R., Hui N., Freemont P., Warren G. Syntaxin 5 is a common component of the NSF- and p97-mediated reassembly pathways of Golgi cisternae from mitotic Golgi fragments in vitro. Cell 1998, 92:603-610.
42. Rabinovich E., Kerem A., Frohlich K.U., Diamant N., Bar-Nun S. AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation. Mol Cell Biol 2002, 22:626-634.
43. Yamanaka K., Sasagawa Y., Ogura T. Recent advances in p97/VCP/Cdc48 cellular functions. Biochim Biophys Acta 2012, 1823:130-137.
44. Meyer H., Bug M., Bremer S. Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system. Nat Cell Biol 2012, 14:117-123.
45. Gonzalez-Perez P., Cirulli E.T., Drory V.E., Dabby R., Nisipeanu P., Carasso R.L., Sadeh M., Fox A., Festoff B.W., Sapp P.C., McKenna-Yasek D., Goldstein D.B., Brown R.H., Blumen S.C. Novel mutation in VCP gene causes atypical amyotrophic lateral sclerosis. Neurology 2012, 79:2201-2208.
46. Nalbandian A., Donkervoort S., Dec E., Badadani M., Katheria V., Rana P., Nguyen C., Mukherjee J., Caiozzo V., Martin B., Watts G.D., Vesa J., Smith C., Kimonis V.E. The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis. J Mol Neurosci 2011, 45:522-531.
47. Tang W.K., Xia D. Altered intersubunit communication is the molecular basis for functional defects of pathogenic p97 mutants. J Biol Chem 2013, 288:36624-36635.
48. Ju J.S., Fuentealba R.A., Miller S.E., Jackson E., Piwnica-Worms D., Baloh R.H., Weihl C.C. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J Cell Biol 2009, 187:875-888.
49. Ju J.S., Miller S.E., Hanson P.I., Weihl C.C. Impaired protein aggregate handling and clearance underlie the pathogenesis of p97/VCP-associated disease. J Biol Chem 2008, 283:30289-30299.
50. Lee J.Y., Koga H., Kawaguchi Y., Tang W., Wong E., Gao Y.S., Pandey U.B., Kaushik S., Tresse E., Lu J., Taylor J.P., Cuervo A.M., Yao T.P. HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy. The EMBO journal 2010, 29:969-980.
51. Nalbandian A., Nguyen C., Katheria V., Llewellyn K.J., Badadani M., Caiozzo V., Kimonis V.E. Exercise training reverses skeletal muscle atrophy in an experimental model of VCP disease. PLoS One 2013, 8:e76187.
52. Darin N., Kyllerman M., Wahlstrom J., Martinsson T., Oldfors A. Autosomal dominant myopathy with congenital joint contractures, ophthalmoplegia, and rimmed vacuoles. Ann Neurol 1998, 44:242-248.
53. Martinsson T., Oldfors A., Darin N., Berg K., Tajsharghi H., Kyllerman M., Wahlstrom J. Autosomal dominant myopathy: missense mutation (Glu-706→Lys) in the myosin heavy chain IIa gene. Proc Natl Acad Sci U S A 2000, 97:14614-14619.
54. Goldfarb L.G., Vicart P., Goebel H.H., Dalakas M.C. Desmin myopathy. Brain 2004, 127:723-734.
55. Pfeffer G., Elliott H.R., Griffin H., Barresi R., Miller J., Marsh J., Evila A., Vihola A., Hackman P., Straub V., Dick D.J., Horvath R., Santibanez-Koref M., Udd B., Chinnery P.F. Titin mutation segregates with hereditary myopathy with early respiratory failure. Brain 2012, 135:1695-1713.